Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about advanced (proliferative) diabetic retinopathy and pars plana ...

Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat ...

VX01-DR-201, is a phase 2, multi-center, double-masked, randomized, placebo-controlled study in patients with moderate to ...

Researchers have observed in a new study that stress hyperglycemia (SHR) ratio could be a useful predictor of neovascular ...

Vasan Eye Care continues to pave the way for better vision and overall improved quality of life for everyone ...

Feature Details Company Milestones and 2025 Catalysts Across Gene Therapy and Ophthalmic ProgramsNEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- PRISM MarketView today published a Q&A feature with Dr.

India holds the unenviable position of being home to the world’s largest diabetic population, with nearly 100 million ...

Loss to follow-up was higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

Kodiak Sciences Inc.’s KOD share price has dipped by 10.63%, which has investors questioning if this is right time to buy.